Clinical Trials Directory

Trials / Completed

CompletedNCT03795064

Immediate Versus Early Endovenous Ablation In Venous Ulcer

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
23 (actual)
Sponsor
Oulu University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study is conducted to assess the effects of immediately started foam sclerotherapy in venous ulcer compared to early intervention.

Detailed description

Recently EVRA study showed that early endovenous ablation (foam sclerotherapy and/or endothermal ablation) is beneficial for venous ulcer healing. This randomized controlled trial is conducted to assess the effects of immediate foam sclerotherapy in the first visit to vascular outpatient clinic (immediate intervention). Patients in control group will receive foam sclerotherapy at four weeks (early intervention). Endothermal ablation is performed in early setting in both groups when truncal vein anatomy is suitable. The primary outcome for this study is the reduction of venous ulcer area at four weeks.

Conditions

Interventions

TypeNameDescription
PROCEDUREFoam sclerotherapyFoam sclerotherapy is used to all patients for endovenous ablation of insufficient veins in subulcer plexus area.
PROCEDUREEndothermal ablationEndothermal ablation is performed in early setting when truncal vein(s) anatomy is suitable.

Timeline

Start date
2018-12-05
Primary completion
2023-01-30
Completion
2023-08-30
First posted
2019-01-07
Last updated
2024-04-03

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT03795064. Inclusion in this directory is not an endorsement.

Immediate Versus Early Endovenous Ablation In Venous Ulcer (NCT03795064) · Clinical Trials Directory